Key Highlights
- Rocket Lab (RKLB) shares climbed 7% on Wednesday following the conclusion of its equity offering program
- The aerospace company issued 6,726,862 shares, generating roughly $474 million in gross capital before fees
- The firm also established collared forward agreements on 7,451,200 shares, potentially bringing in up to $642 million
- Capital will fund expansion initiatives, possible strategic acquisitions, and operational requirements
- Citizens JMP raised its rating on RKLB to Outperform with an $85 target on April 7
Rocket Lab (RKLB) successfully concluded its at-the-market equity program on Wednesday, issuing 6,726,862 shares that generated approximately $474 million in gross capital prior to commissions and related costs.
The capital raise connected to a prospectus supplement the company filed on March 17, 2026, which permitted the aerospace firm to issue as much as $1 billion in equity through at-the-market sales.
In addition to the direct share issuance, Rocket Lab structured collared forward agreements encompassing 7,451,200 shares. These arrangements guarantee minimum proceeds of $474 million while establishing a maximum threshold of roughly $642 million.
The forward agreements carry an April 2028 maturity date. Final proceeds will vary based on whether Rocket Lab exercises early settlement options and the specific cap and floor pricing embedded in each contract.
Rocket Lab indicated the capital will support expansion efforts, potential strategic acquisitions, and general corporate operations and working capital requirements. The company did not disclose specific acquisition candidates.
Shares advanced following the announcement as broader market indices also posted gains during Wednesday’s trading session.
Citizens JMP Issues Bullish Call
Just one day prior to the offering’s completion, on April 7, Citizens JMP elevated RKLB from Market Perform to Outperform, establishing an $85 price objective.
The investment firm highlighted Rocket Lab’s launch operations, defense-focused space systems, and what it characterized as an “increasingly clear pathway toward higher-margin” space services as catalysts behind the rating increase.
Citizens JMP noted the current valuation represents an attractive opportunity, supported by a “convergence of multiple strategic and macroeconomic dynamics.” The firm anticipates “meaningful appreciation potential” throughout the coming 12 months and beyond.
The analyst team also emphasized favorable geopolitical conditions and funding dynamics within the space industry as positive factors for the company’s outlook.
The rating enhancement came precisely as Rocket Lab was finalizing a capital injection that surpassed the minimum guaranteed level established in its forward contracts.
Financing Structure Breakdown
The at-the-market mechanism provides Rocket Lab operational flexibility regarding timing and execution pricing, contrasting with conventional offerings that establish fixed pricing parameters.
This approach enabled the company to capitalize on favorable market conditions, which evidently materialized during this week’s transactions.
The collared forward mechanism additionally establishes a minimum proceeds guarantee, mitigating exposure to adverse price movements ahead of the April 2028 settlement dates.
Combining the completed share sales with the forward commitments, Rocket Lab has secured or committed to securing between approximately $948 million and $1.116 billion in aggregate capital from this initiative.
The $1 billion offering authorization specified in the March 17 prospectus has essentially been satisfied or surpassed when accounting for both program elements.
Wednesday’s closing price demonstrated investor approval of a capital raising effort that achieved — and potentially exceeded — the company’s announced objectives.


